Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study.

BACKGROUND AND AIM A cluster of metabolic factors defines a syndrome that predisposes to diabetes and cardiovascular disease. Chronic infections such as periodontitis might alter these individual metabolic factors and the systemic inflammatory burden. The aim of this study was to investigate the association between severe periodontitis and increase in inflammatory and metabolic risk factors for cardiovascular disease. MATERIALS AND METHODS We examined 302 patients with severe periodontitis and 183 healthy controls, and we collected a blood sample from each subject in order to investigate differences in inflammatory (leukocyte numbers and differential counts) and metabolic markers (lipids and glucose). RESULTS After correcting for differences in age, gender, smoking and ethnicity, periodontitis subjects exhibited a low-grade systemic inflammation (increased white cell counts, 1.10+/-1.02 x 10(9)/l, 95%CI 1.05-1.15, p=0.0001), dyslipidemia [lower high-density lipoprotein cholesterol, 1.14+/-1.03 mmol/l, 95%CI 1.08-1.20, p<0.0001 and higher low-density lipoprotein cholesterol, 1.12+/-1.03, 95%CI 1.05-1.19, p<0.0001) and increased non-fasting serum glucose levels (1.04+/-1.01 mmol/l, 95%CI 1.02-1.06, p=0.01) when compared with controls. The associations were confirmed in a subpopulation of Caucasian non-smokers. A trend for a dose dependent effect of the number of periodontal pockets on the tested inflammatory and metabolic markers was observed. CONCLUSIONS These data suggest a possible link between severe generalized periodontitis, systemic inflammation and a dysmetabolic state in otherwise healthy individuals.

[1]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Circulation.

[2]  A. Kage,et al.  White blood cell count in generalized aggressive periodontitis after non-surgical therapy. , 2002, Journal of clinical periodontology.

[3]  J. Knight,et al.  NADPH oxidase (CYBA) and FcgammaR polymorphisms as risk factors for aggressive periodontitis: a case-control association study. , 2006, Journal of clinical periodontology.

[4]  F. Chandad,et al.  Modulation of cytokine production by Porphyromonas gingivalis in a macrophage and epithelial cell co-culture model. , 2005, Microbes and infection.

[5]  C. Alvarez,et al.  Lipids, lipoproteins, and apoproteins in serum during infection. , 1986, Clinical chemistry.

[6]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[7]  D. Remick,et al.  Cytokine Responses of Human Blood Monocytes Stimulated with Igs , 1997, Inflammation.

[8]  Shinya Murakami,et al.  Consensus Report: Aggressive Periodontitis , 1999 .

[9]  M. Tonetti,et al.  Short-term Effects of Intensive Periodontal Therapy on Serum Inflammatory Markers and Cholesterol , 2005, Journal of dental research.

[10]  C. Cutler,et al.  Association between periodontitis and hyperlipidemia: cause or effect? , 1999, Journal of periodontology.

[11]  J. Gunsolley,et al.  Smoking and its effects on early-onset periodontitis. , 1995, Journal of the American Dental Association.

[12]  S. Haffner,et al.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). , 2000, Circulation.

[13]  G. Griffiths,et al.  Periodontal status among relatives of aggressive periodontitis patients and reliability of family history report. , 2006, Journal of clinical periodontology.

[14]  N Claffey,et al.  Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology. , 2005, Journal of clinical periodontology.

[15]  K. Feingold,et al.  Tumor necrosis factor-alpha stimulates hepatic lipogenesis in the rat in vivo. , 1987, The Journal of clinical investigation.

[16]  M. Tonetti,et al.  Periodontitis and Systemic Inflammation: Control of the Local Infection is Associated with a Reduction in Serum Inflammatory Markers , 2004, Journal of dental research.

[17]  U. van der Velden,et al.  Lymphocyte numbers and function in relation to periodontitis and smoking. , 2004, Journal of periodontology.

[18]  D. Lackland,et al.  Addressing the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Metabolic Syndrome in the Southeastern United States, Part II: Treatment Recommendations for Management of the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Meta , 2005, The American journal of the medical sciences.

[19]  G. Belibasakis,et al.  Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin. , 2005, Cytokine.

[20]  A. Gustafsson,et al.  Risk factors for cardiovascular disease in patients with periodontitis. , 2003, European heart journal.

[21]  I. Kushner,et al.  Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.

[22]  Imran Awan,et al.  Leukocyte count and coronary heart disease: implications for risk assessment. , 2004, Journal of the American College of Cardiology.

[23]  D. Deen.  Metabolic syndrome: time for action. , 2004, American family physician.

[24]  M. Revel.  Host defense against infections and inflammations: Role of the multifunctional IL-6/IFN-β2 cytokine , 1989, Experientia.

[25]  E. L. Batista,et al.  Role for Periodontitis in the Progression of Lipid Deposition in an Animal Model , 2003, Infection and Immunity.

[26]  B. Uretsky,et al.  Covered stent septal ablation for hypertrophic obstruction cardiomyopathy. , 2004, Circulation.

[27]  Kenneth R Feingold,et al.  Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. , 2004, Journal of lipid research.

[28]  J. Gallin,et al.  Serum lipids in infection. , 1969, The New England journal of medicine.

[29]  F. Hoek,et al.  Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. , 2000, Journal of periodontology.

[30]  G. Armitage,et al.  Development of a classification system for periodontal diseases and conditions. , 1999, Annals of periodontology.

[31]  M. Flugelman,et al.  Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. , 2002, Journal of periodontology.

[32]  G. Reaven.  Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. , 2005, Cell metabolism.

[33]  C. Cutler,et al.  Pathophysiological relationships between periodontitis and systemic disease: recent concepts involving serum lipids. , 2000, Journal of periodontology.

[34]  M. Tonetti,et al.  Gene polymorphisms in pro-inflammatory cytokines are associated with systemic inflammation in patients with severe periodontal infections. , 2004, Cytokine.

[35]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[36]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[37]  M. Tonetti,et al.  Early-onset periodontitis. , 1999, Annals of periodontology.

[38]  Y. Kiyohara,et al.  The Severity of Periodontal Disease is Associated with the Development of Glucose Intolerance in Non-diabetics: The Hisayama Study , 2004, Journal of dental research.

[39]  P. Ridker,et al.  Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. , 2004, Circulation.

[40]  A. Mombelli,et al.  Can presence or absence of periodontal pathogens distinguish between subjects with chronic and aggressive periodontitis? A systematic review. , 2002, Journal of clinical periodontology.